Sanofi Wins Injunction In Sun IP Suit Over Eloxatin

Law360, New York (February 17, 2011, 8:53 PM EST) -- Sanofi-Aventis LLC won a preliminary injunction barring Sun Pharmaceuticals Industries Ltd. from selling a generic version of Sanofi's colon cancer drug Eloxatin, after an agreement between the parties to temporarily halt Sun's sales of the drug expired earlier this week.

Judge Joel A Pisano of the U.S. District Court District of New Jersey issued an order Wednesday granting Sanofi's request for the injunction, a day before the agreement with Sun and its subsidiary, Caraco Pharmaceuticals Laboratories Inc., was set to expire.

Sun agreed last week to...
To view the full article, register now.